Loading...
Rifaximin, gut microbes and mucosal inflammation: unraveling a complex relationship
Rifaximin is a non-systemic, broad-spectrum antibiotic that acts against gram-positive, gram-negative, and anaerobic bacteria. Clinical studies indicate that rifaximin is beneficial in treating irritable bowel syndrome (IBS). The mechanism responsible for the beneficial effects of rifaximin is not c...
Na minha lista:
| Udgivet i: | Gut Microbes |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5915365/ https://ncbi.nlm.nih.gov/pubmed/25244596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/gmic.32130 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|